Maternal serum placental leucine aminopeptidase (P-LAP)/oxytocinase and preterm delivery

International Journal of Gynecology and Obstetrics

Volumn 73, Issue 3, 2001, Pages 207-213

  Kozaki, H ^a   Itakura, A ^a   Okamura, M ^a   Ohno, Y ^b   Wakai, K ^a   Mizutani, S ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Oxytocinase; P LAP; Preterm delivery

Indexed keywords

BIOLOGICAL MARKER; CYSTYL AMINOPEPTIDASE; CYTOSOL AMINOPEPTIDASE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BLOOD LEVEL; FEMALE; HIGH RISK PREGNANCY; HOSPITAL ADMISSION; HUMAN; INCIDENCE; LABOR; MAJOR CLINICAL STUDY; MATERNAL SERUM; MULTICENTER STUDY; PARAMETER; PREMATURE LABOR; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EID: 0035370174     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(01)00372-1     Document Type: Article

References (25)

1. Creasy R.K. Preterm birth prevention: where are we? Am J Obstet Gynecol. 168:1993;1223-1230.
2. Grimes D.A., Schulz K.F. Randomized controlled trials of home uterine activity monitoring: a review and critique. Obstet Gynecol. 79:1992;137-142.
3. Cunningham F.G., MacDonald P.C., Gant N.F., Leveno K.J., Gilstrap L.C. I.I.I., Hankins G.D.V., Clark S.L., Williams Obstetrics. 20th edition :1997;Appleton and Lange, Norwalk, Connecticut.
4. Mclean M., Bisits A., Davies J., Woods R., Lowry P., Smith R. A placental clock controlling the length of human pregnancy. Nat Med. 1:1996;460-463.
5. Mizutani S., Yoshino M., Oya M. Placental and non-placental leucine aminopeptidases during normal pregnancy. Clin Biochem. 9:1976;16-18.
6. Tsujimoto M., Mizutani S., Adachi H., Kimura M., Nakazato H., Tomoda Y. Identification of human placental leucine aminopeptidase as oxytocinase. Arc Biochem Biophys. 292:1992;388-392.
7. Naruki M., Mizutani S., Goto K., Tsujimoto M., Nakazato H., Itakura A., et al. Oxytocin is hydrolyzed by an enzyme in human placenta that is identical to the oxytocinase of pregnancy serum. Peptides. 17:1996;257-261.
8. Rogi T., Tsujimoto M., Nakazato H., Mizutani S., Tomoda Y. Human placental leucine aminopeptidase/oxytocinase. J Biol Chem. 271:1996;56-61.
9. Mizutani S., Safwat M.A., Goto K., Tsujimoto M., Nakazato H., Itakura A., et al. Preterm initiating and responsible enzyme of arginine vasopressin degradation in human placenta and pregnancy serum. Regul Peptides. 59:1995;371-378.
10. Mizutani S., Itakura A., Kurauchi O., Kikkawa F., Tomoda Y. Maternal serum oxytocinase activities in patients with poor obstetric dates. Med Sci Res. 22:1994;771-775.
11. Kimura T., Tanizawa O., Mori K., Brownstein M.J., Okayama H. Structure and expression of human oxytocin receptor. Nature. 356:1992;526-529.
12. Wilson L. Jr., Parsons M.T., Ouano L., Flouret G. A new tocolyric agent: development of an oxytocin antagonist for inhibiting uterine contractions. Am J Obstet Gynecol. 163:1990;195-202.
13. Matthews S.G. Hypothalamic oxytocin in the developing ovine fetus: interaction with pituitary-adrenocortical function. Brain Res. 820:1999;92-100.
14. Morris M., Castro M., Rose J.C. Alterations in oxytocin prohormone processing during early development in the fetal sheep. Am J Physiol. 263:1992;R738-740.
15. Yamahara N., Nomura S., Suzuki T., Itakura A., Ito M., Okamoto T., et al. Placental leucine aminopeptidase/oxytocinase in maternal serum and placenta during normal pregnancy. Life Sci. 66:2000;1401-1410.
16. Behrens O., Bohmer S., Goeschen K., Fuchs A.R. Plasma oxytocin but not prostaglandin F2 alpha metabolite levels at cerclage may predict preterm delivery. Obstet Gynecol. 77:1991;879-884.
17. Valenzuela G.J., Sanchez-Ramos L., Romero R., Silver H.M., Koltun W.D., Millar L., et al. Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group. Am J Obstet Gynecol. 182:2000;1184-1190.
18. Lockwood C.J., Senyei A.E., Dische M.R., Casal D., Shah K.D., Thung S.N., et al. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. New Engl J Med. 325:1991;669-674.
19. Yoon B.H., Yang S.H., Jun J.K., Park K.H., Kim C.J., Romero R. Maternal blood C-reactive protein, white blood cell count, and temperature in preterm labor: a comparison with amniotic fluid white blood cell count. Obstet Gynecol. 87:1996;231-237.
20. Wadhwa P.D., Dunkel-Schetter C., Chicz-DeMet A., Porto M., Sandman C.A. Prenatal psychosocial factors and the neuroendocrine axis in human pregnancy. Psychosom Med. 58:1996;432-446.
21. Hobel C.J., Dunkel-Schetter C., Roesch S.C., Castro L.C., Arora C.P. Maternal plasma corticotropin-releasing hormone associated with stress at 20 weeks' gestation in pregnancies ending in preterm delivery. Am J Obstet Gynecol. 180:1999;257-263.
22. Steer P., Flint C. Prenatal labor and premature rupture of membranes. Br J Obstet Gynaecol. 17:1999;1059-1062.
23. Liggins G.C. Hormonal interaction in the mechanism of parturition. Men Soc Endocrinol. 20:1973;119-139.
24. Darne J., McGarrigle H.H., Lachelin G.C. Increased saliva oestriol to progesterone ratio before preterm delivery: a possible predictor for preterm labor? BMJ. 294:1987;270-272.
25. Horio J., Nomura S., Okada M., Katsumata Y., Nakanishi Y., Kumano Y., et al. Structural organization of the 5′-end and chromosomal assignment of human placental leucine aminopeptidase/insulin-regulated membrane aminopeptidase gene. Biochem Biophys Res Commun. 262:1999;269-274.